Revenue, 2025
USD 3.15 Bn
Forecast Year, 2034
USD 5.56
CAGR, 2025 - 2034
6.51%
Report Coverage
Worldwide
The global clinical trial supplies market, valued at over USD 3.15 billion in 2025, is projected to grow to USD 5.56 billion by 2034, expanding at a CAGR of 6.51%, driven by increasing clinical research and pharmaceutical R&D activities worldwide.
Clinical Trial Supplies Market Size Analysis
Clinical Trial Supplies Market Size By Phases 2025 to 2034 (USD Billion)
| Phases | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I | 0.32 | 0.34 | 0.36 | 0.38 | 0.41 | 0.43 | 0.47 | 0.49 | 0.53 | 0.55 |
| Phase II | 0.63 | 0.67 | 0.72 | 0.76 | 0.81 | 0.87 | 0.92 | 0.98 | 1.05 | 1.11 |
| Phase III | 0.94 | 1.01 | 1.07 | 1.14 | 1.22 | 1.29 | 1.38 | 1.47 | 1.56 | 1.67 |
| Phase IV | 1.26 | 1.34 | 1.43 | 1.52 | 1.62 | 1.72 | 1.84 | 1.96 | 2.08 | 2.22 |
Clinical Trial Supplies Market Size By Services 2025 to 2034 (USD Billion)
| Services | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Logistics & distribution | 0.15 | 0.16 | 0.17 | 0.18 | 0.20 | 0.21 | 0.22 | 0.24 | 0.25 | 0.27 |
| Storage & Retention | 0.30 | 0.32 | 0.34 | 0.36 | 0.39 | 0.41 | 0.44 | 0.47 | 0.50 | 0.53 |
| Supply Chain Management | 0.45 | 0.48 | 0.51 | 0.55 | 0.58 | 0.62 | 0.66 | 0.70 | 0.74 | 0.79 |
| Packaging, labeling, and blinding | 0.60 | 0.64 | 0.68 | 0.72 | 0.77 | 0.82 | 0.88 | 0.93 | 0.99 | 1.06 |
| Manufacturing | 0.75 | 0.80 | 0.85 | 0.91 | 0.96 | 1.03 | 1.09 | 1.17 | 1.24 | 1.32 |
| Comparator sourcing | 0.90 | 0.96 | 1.02 | 1.09 | 1.16 | 1.23 | 1.31 | 1.40 | 1.49 | 1.59 |
Clinical Trial Supplies Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharma & Biotech companies | 0.53 | 0.56 | 0.60 | 0.63 | 0.68 | 0.72 | 0.77 | 0.82 | 0.87 | 0.93 |
| Contract Research Organization (CRO) | 1.05 | 1.12 | 1.19 | 1.27 | 1.35 | 1.44 | 1.53 | 1.63 | 1.74 | 1.85 |
| Medical Device Companies | 1.57 | 1.67 | 1.78 | 1.90 | 2.02 | 2.16 | 2.30 | 2.44 | 2.61 | 2.78 |
Clinical Trial Supplies Market Size By Therapeutic Area 2025 to 2034 (USD Billion)
| Therapeutic Area | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 0.07 | 0.07 | 0.08 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.12 | 0.12 |
| CNS & mental disorders | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.21 | 0.22 | 0.23 | 0.25 |
| Cardiovascular | 0.21 | 0.22 | 0.24 | 0.25 | 0.27 | 0.29 | 0.31 | 0.33 | 0.35 | 0.37 |
| Digestive disorders | 0.28 | 0.30 | 0.32 | 0.34 | 0.36 | 0.38 | 0.41 | 0.43 | 0.46 | 0.49 |
| Infectious diseases | 0.35 | 0.37 | 0.40 | 0.42 | 0.45 | 0.48 | 0.51 | 0.55 | 0.58 | 0.62 |
| Metabolic disorders | 0.42 | 0.45 | 0.48 | 0.51 | 0.54 | 0.58 | 0.61 | 0.65 | 0.70 | 0.74 |
| Immunology | 0.49 | 0.52 | 0.56 | 0.59 | 0.63 | 0.67 | 0.72 | 0.76 | 0.81 | 0.86 |
| Blood disorders | 0.56 | 0.60 | 0.64 | 0.68 | 0.72 | 0.77 | 0.82 | 0.87 | 0.93 | 0.99 |
| Other therapeutic areas (dermatological disorders, rare diseases, ENT diseases, Nephrology) | 0.63 | 0.67 | 0.71 | 0.76 | 0.81 | 0.86 | 0.92 | 0.98 | 1.04 | 1.11 |
Clinical Trial Supplies Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.32 | 0.34 | 0.36 | 0.38 | 0.41 | 0.44 | 0.47 | 0.50 | 0.53 | 0.56 |
| LAMEA | 0.63 | 0.67 | 0.71 | 0.77 | 0.81 | 0.86 | 0.92 | 0.98 | 1.04 | 1.11 |
| Europe | 0.95 | 1.00 | 1.07 | 1.14 | 1.21 | 1.29 | 1.37 | 1.47 | 1.56 | 1.66 |
| Asia-Pacific | 1.26 | 1.34 | 1.43 | 1.52 | 1.62 | 1.73 | 1.84 | 1.96 | 2.08 | 2.22 |
Clinical Trial Supplies Market Size to Hit USD 5.56 Billion by 2034
The global clinical trial supplies market size surpassed USD 3.15 billion in 2025 and is predicted to reach around USD 5.56 billion by 2034 with a registering a CAGR of 6.51%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com